Robin M. Yates, David G. Russell  Immunity 

Slides:



Advertisements
Similar presentations
Figure 8. Colocalization of β-Arrestin2-GFP with Internalized wt and S(483–498)A Mutant PTHRs HEK-wt PTHR and HEK-S(483–498)A PTHR cells were transiently.
Advertisements

The Chagas' Disease Parasite Trypanosoma cruzi Exploits Nerve Growth Factor Receptor TrkA to Infect Mammalian Hosts  Milena de Melo-Jorge, Mercio PereiraPerrin 
Volume 9, Issue 5, Pages (November 1998)
The Small-Molecule Iron Transport Inhibitor Ferristatin/NSC Promotes Degradation of the Transferrin Receptor  Lior Horonchik, Marianne Wessling-Resnick 
Volume 44, Issue 6, Pages (June 2016)
Toll-like Receptors Keep Antigen Sorting on the Right Track
Volume 28, Issue 2, Pages (February 2008)
The Phagosomal Proteome in Interferon-γ-Activated Macrophages
2008: A MyD88 O, DC  Bali Pulendran, Weiping Cao  Immunity 
Volume 26, Issue 3, Pages (March 2007)
Volume 33, Issue 4, Pages (October 2010)
Volume 34, Issue 3, Pages (March 2011)
Toll-like Receptor 9: AEP Takes Control
JAK3 Specific Kinase Inhibitors: When Specificity Is Not Enough
Volume 16, Issue 22, Pages (November 2006)
Volume 36, Issue 5, Pages (May 2012)
The Plasticity of the Hsp90 Co-chaperone System
Volume 47, Issue 5, Pages e6 (November 2017)
Research Techniques Made Simple: Methodology and Applications of Förster Resonance Energy Transfer (FRET) Microscopy  Joshua A. Broussard, Kathleen J.
Volume 4, Issue 4, Pages (October 2008)
Volume 16, Issue 1, Pages (January 2002)
Volume 27, Issue 1, Pages (July 2007)
Volume 127, Issue 5, Pages (November 2004)
Volume 26, Issue 5, Pages (May 2007)
Volume 43, Issue 6, Pages (December 2015)
Volume 36, Issue 5, Pages (May 2012)
Volume 7, Issue 1, Pages (January 2010)
Volume 47, Issue 4, Pages e3 (October 2017)
Volume 25, Issue 6, Pages (December 2006)
Phagocytosis: An Immunobiologic Process
Volume 22, Issue 4, Pages (April 2005)
Volume 15, Issue 6, Pages (June 2012)
Volume 19, Issue 7, Pages (July 2012)
Inflammasome Activation: How Macrophages Watch What They Eat
Volume 66, Issue 5, Pages e4 (June 2017)
Volume 37, Issue 6, Pages (December 2012)
Volume 25, Issue 5, Pages (November 2006)
Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling
Volume 27, Issue 1, Pages (July 2007)
Mycobacterium tuberculosis Invasion of Macrophages: Linking Bacterial Gene Expression to Environmental Cues  Kyle H. Rohde, Robert B. Abramovitch, David.
Volume 38, Issue 3, Pages (March 2013)
Volume 32, Issue 4, Pages (April 2010)
Volume 37, Issue 2, Pages (August 2012)
Volume 25, Issue 2, Pages (August 2006)
The Strength of T Cell Receptor Signal Controls the Polarization of Cytotoxic Machinery to the Immunological Synapse  Misty R. Jenkins, Andy Tsun, Jane.
Volume 30, Issue 5, Pages (May 2009)
Volume 27, Issue 3, Pages (September 2007)
IL-1 Can Act as Number One
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Volume 2, Issue 4, Pages (October 2005)
Volume 24, Issue 3, Pages (March 2006)
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Richard W. Deibler, Marc W. Kirschner  Molecular Cell 
Protein Kinase D Is an Essential Regulator of C
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Ligand-Driven Vectorial Folding of Ribosome-Bound Human CFTR NBD1
Volume 30, Issue 6, Pages (June 2009)
Volume 32, Issue 2, Pages (February 2010)
Volume 40, Issue 4, Pages (April 2014)
Volume 12, Issue 9, Pages (September 2005)
Volume 26, Issue 3, Pages (March 2007)
Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase  Parameswaran Ramakrishnan,
Volume 8, Issue 2, Pages (February 1998)
Recycling Endosomes and TLR Signaling— The Rab11 GTPase Leads the Way
Volume 28, Issue 3, Pages (March 2008)
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Volume 156, Issue 4, Pages (February 2014)
Volume 31, Issue 5, Pages (November 2009)
Altered Peptide Ligands Induce Delayed CD8-T Cell Receptor Interaction—a Role for CD8 in Distinguishing Antigen Quality  Pia P. Yachi, Jeanette Ampudia,
Volume 24, Issue 3, Pages (March 2006)
Presentation transcript:

Phagosome Maturation Proceeds Independently of Stimulation of Toll-like Receptors 2 and 4  Robin M. Yates, David G. Russell  Immunity  Volume 23, Issue 4, Pages 409-417 (October 2005) DOI: 10.1016/j.immuni.2005.09.007 Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 1 Binding of Man Beads to Macrophages Is Inhibitable by Soluble Mannan and Only Activates TLRs when Coated in Pam3 or LPS (A and B) The binding of Man beads with or without conjugated carboxyfluorescein was examined in the presence of 10 mg/ml soluble mannan. Beads were allowed to bind to macrophage monolayers for 3 min at room temperature. The degree of binding of the washed monolayers was enumeration by microscopy (A) for Man beads, or determined by fluorescent intensity for fluorescent Man beads (B). (C) An immunoblot illustrating the degradation of IκBα and phosphorylation of p38 MAP kinase in BMMØ following phagocytosis of Man beads with or without adsorbed Pam3 or LPS in wt (C57BL/6 and C3H/HeN) and mutant BMMØ defective in TLR2 and TLR4 signaling (TLR2−/− and C3H/HeJ). Loading controls demonstrated equivalent amounts of total p38 MAP kinase between samples (data not shown). Immunity 2005 23, 409-417DOI: (10.1016/j.immuni.2005.09.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 2 Acidification of Phagosomes Containing Man Beads and IgG Beads Proceeds Independently of Stimulation of TLR2 or TLR4 (A and B) Ratio fluorometry was used to calculate the pH of phagosomes following uptake of Man beads (A) ± adsorbed Pam3 in wt (C57BL/6) and TLR2−/− BMMØ, and (B) ± adsorbed LPS in wt (C3H/HeN) and TLR4 signaling-defective (C3H/HeJ) BMMØ. (C and D) And following uptake of IgG beads (C) ± adsorbed Pam3 in wt (C57BL/6) and TLR2−/− BMMØ and (D) ± adsorbed LPS in wt (C3H/HeN) and TLR4 signaling-defective (C3H/HeJ) BMMØ. (E) The acidification profile of IgG bead-containing phagosomes generated by C57BL/6 macrophages in the presence of the V-ATPase inhibitor Concanamycin A (100 nM) or the calmodulin inhibitor W7 (15 μM). Fluorescent emission at 520 nm was measured using alternating excitation wavelengths of 450 nm and 490 nm. These experiments were conducted a minimum of four times. Immunity 2005 23, 409-417DOI: (10.1016/j.immuni.2005.09.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 3 Phagosomes Formed in the Presence or Absence of TLR2 or TLR4 Signaling Display Comparable Phagosome/Lysosome Fusion Profiles (A and B) A FRET-based assay measuring the access of a particle-associated donor fluor to a lysosome-localized acceptor fluor was used to quantify phagosome/lysosome mixing following uptake of (A) Man beads ± adsorbed Pam3 in wt (C57BL/6) and TLR2−/− BMMØ, or (B) Man beads ± adsorbed LPS in wt (C3H/HeN) and TLR4 signaling-defective (C3H/HeJ) BMMØ. (C) To validate the assay, wt (C57BL/6) BMMØ were incubated with Man beads in the presence of known inhibitors of phagosomal maturation, including 100 nM Concanamycin A (V-ATPase) and 15 μM W7 (calmodulin). All experiments were conducted a minimum of four times. Immunity 2005 23, 409-417DOI: (10.1016/j.immuni.2005.09.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 4 Stimulation of TLR2 or TLR4 Does Not Affect the Kinetics of Phagosomal Acidification after Uptake via the Phosphatidylserine Receptor Acidification profiles of phagosomes following uptake of particles coated with phosphatidylserine ± Pam3 or LPS in wt (C57BL/6) macrophages. Fluorescent emission at 520 nm was taken every 2 s by use of alternating excitation wavelengths of 450 nm and 490 nm and pH was calculated as detailed (Yates et al., 2005). All experiments were conducted a minimum of four times. Immunity 2005 23, 409-417DOI: (10.1016/j.immuni.2005.09.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 5 MyD88−/− Macrophages Show Altered Phagosome/Lysosome Fusion Compared to Wild-Type Macrophages Independent of the Presence of TLR Ligands The FRET-based assay was used to quantify phagosome/lysosome mixing following uptake of (A) Man beads ± Pam3 in wt (C57BL/6/129F2) and MyD88−/− BMMØ, or (B) Man beads ± LPS in wt (C57BL/6/129F2) and MyD88−/− BMMØ. In the presence or absence of TLR ligand, the MyD88−/− BMMØ displayed reduced rates of fusion at 90 and 180 min compared to wt BMMØ (p < 0.0001 based on ANOVA). All experiments were conducted a minimum of four times. Immunity 2005 23, 409-417DOI: (10.1016/j.immuni.2005.09.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 6 MyD88−/− Macrophages Show Altered Kinetics of Phagosomal Acidification Compared to Wild-Type Macrophages Independent of the Presence of TLR Ligands Ratio fluorometry was used to calculate the pH of phagosomes following uptake of Man beads ± adsorbed Pam3 or LPS in wt (C57BL/6/129F2) and MyD88−/− BMMØ. Fluorescent emission at 520 nm was measured using alternating excitation wavelengths of 450 nm and 490 nm. These experiments were conducted a minimum of four times. Immunity 2005 23, 409-417DOI: (10.1016/j.immuni.2005.09.007) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 7 Phagosomes Containing Staphylococcus aureus Formed in the Presence or Absence of TLR2 or TLR4 Signaling Exhibit Comparable Phagosome/Lysosome Fusion Profiles (A) The FRET-based assay was used to quantify phagosome/lysosome mixing following uptake of formalin-fixed S. aureus ± LPS in wt (C57BL/6) and TLR2−/− BMMØ. Data are presented as an average over four individual sets of data. (B) Degradation of IκBα and phosphorylation of p38 MAP kinase in the macrophage were examined by immunoblotting following phagocytosis of S. aureus particles with or without incorporated LPS in wt (C57BL/6) and TLR2−/− BMMØ. Loading controls demonstrated equivalent amounts of total p38 MAP kinase between samples (data not shown). Immunity 2005 23, 409-417DOI: (10.1016/j.immuni.2005.09.007) Copyright © 2005 Elsevier Inc. Terms and Conditions